Home LiteratureArticle Details
PMID: 12407441 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

MRI of mouse models for gliomas shows similarities to humans and can be used to identify mice for preclinical trials.

Neoplasia (New York, N.Y.) ·Vol. 4 ·No. 6 ·2002-00-00 ·Pages 480-5

Koutcher JA, Hu X, Xu S, Gade TP, Leeds N, Zhou XJ, Zagzag D, Holland EC

Abstract

Magnetic resonance imaging (MRI) has been utilized for screening and detecting brain tumors in mice based upon their imaging characteristics appearance and their pattern of enhancement. Imaging of these tumors reveals many similarities to those observed in humans with identical pathology. Specifically, high-grade murine gliomas have histologic characteristics of glioblastoma multiforme (GBM) with contrast enhancement after intravenous administration of gadolinium diethylenetriamine pentaacetic acid (Gd-DTPA), implying disruption of the blood-brain barrier in these tumors. In contrast, low-grade murine oligodendrogliomas do not reveal contrast enhancement, similar to human tumors. MRI can be used to identify mice with brain neoplasms as inclusion criteria in preclinical trials.

MeSH Terms
Animals Brain Neoplasms/diagnosis,diagnostic imaging,pathology Disease Models, Animal ErbB Receptors/genetics,metabolism Gadolinium DTPA Glioblastoma/diagnosis,diagnostic imaging,pathology Humans Magnetic Resonance Imaging/methods Mice Mice, Transgenic Protein Serine-Threonine Kinases Proto-Oncogene Proteins/metabolism Proto-Oncogene Proteins c-akt Radiography Retroviridae/genetics ras Proteins/metabolism
Chemicals
Proto-Oncogene Proteins ErbB Receptors Protein Serine-Threonine Kinases Proto-Oncogene Proteins c-akt ras Proteins Gadolinium DTPA
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Koutcher Jason A
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA. [email protected]
Hu Xiaoyi
Xu Su
Gade Terence P F
Leeds Norman
Zhou Xiaohong Joe
Zagzag David
Holland Eric C
References (31)
31 references, click to expand
  1. Gliomas in rodent whisker barrel cortex: a new tumor model.
    J Neurosurg. 1999 Nov;91(5):814-21 PMID: 10541239
  2. A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell-cycle arrest pathways to induce glioma-like lesions in mice.
    Genes Dev. 1998 Dec 1;12(23):3675-85 PMID: 9851974
  3. Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade.
    AJNR Am J Neuroradiol. 2000 May;21(5):891-9 PMID: 10815665
  4. Diffusion MRI detects early events in the response of a glioma model to the yeast cytosine deaminase gene therapy strategy.
    Gene Ther. 2000 Jun;7(12):1005-10 PMID: 10871748
  5. Optical coherence tomography: an emerging technology for biomedical imaging and optical biopsy.
    Neoplasia. 2000 Jan-Apr;2(1-2):9-25 PMID: 10933065
  6. Use of reporter genes for optical measurements of neoplastic disease in vivo.
    Neoplasia. 2000 Jan-Apr;2(1-2):41-52 PMID: 10933067
  7. Intravital fluorescence videomicroscopy to study tumor angiogenesis and microcirculation.
    Neoplasia. 2000 Jan-Apr;2(1-2):53-61 PMID: 10933068
  8. High resolution X-ray computed tomography: an emerging tool for small animal cancer research.
    Neoplasia. 2000 Jan-Apr;2(1-2):62-70 PMID: 10933069
  9. Characterizing tumors using metabolic imaging: PET imaging of cellular proliferation and steroid receptors.
    Neoplasia. 2000 Jan-Apr;2(1-2):71-88 PMID: 10933070
  10. Fluorescence spectroscopy of neoplastic and non-neoplastic tissues.
    Neoplasia. 2000 Jan-Apr;2(1-2):89-117 PMID: 10933071
  11. Imaging transgene expression with radionuclide imaging technologies.
    Neoplasia. 2000 Jan-Apr;2(1-2):118-38 PMID: 10933072
  12. Applications of magnetic resonance in model systems: cancer therapeutics.
    Neoplasia. 2000 Jan-Apr;2(1-2):152-65 PMID: 10933074
  13. Noninvasive assessment of tumor cell proliferation in animal models.
    Neoplasia. 1999 Oct;1(4):303-10 PMID: 10935484
  14. Imaging prostate cancer invasion with multi-nuclear magnetic resonance methods: the Metabolic Boyden Chamber.
    Neoplasia. 2000 May-Jun;2(3):273-9 PMID: 10935513
  15. HGF/SF activates glycolysis and oxidative phosphorylation in DA3 murine mammary cancer cells.
    Neoplasia. 2000 Jul-Aug;2(4):365-77 PMID: 11005571
  16. Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging.
    Clin Cancer Res. 1997 Sep;3(9):1457-66 PMID: 9815831
  17. Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography.
    Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):2333-8 PMID: 10051642
  18. Development of a flexible and specific gene delivery system for production of murine tumor models.
    Oncogene. 1999 Sep 20;18(38):5253-60 PMID: 10498877
  19. Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors.
    J Natl Cancer Inst. 2000 Dec 20;92(24):2029-36 PMID: 11121466
  20. Gliomagenesis: genetic alterations and mouse models.
    Nat Rev Genet. 2001 Feb;2(2):120-9 PMID: 11253051
  21. Vascular differences detected by MRI for metastatic versus nonmetastatic breast and prostate cancer xenografts.
    Neoplasia. 2001 Mar-Apr;3(2):143-53 PMID: 11420750
  22. PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo.
    Genes Dev. 2001 Aug 1;15(15):1913-25 PMID: 11485986
  23. Magnetic resonance imaging of ethyl-nitrosourea-induced rat gliomas: a model for experimental therapeutics of low-grade gliomas.
    J Neurooncol. 2001 Jul;53(3):243-57 PMID: 11718257
  24. Imaging TCR-dependent NFAT-mediated T-cell activation with positron emission tomography in vivo.
    Neoplasia. 2001 Nov-Dec;3(6):480-8 PMID: 11774030
  25. Magnetic labeling of activated microglia in experimental gliomas.
    Neoplasia. 2001 Nov-Dec;3(6):489-99 PMID: 11774031
  26. Comparison of permeability in high-grade and low-grade brain tumors using dynamic susceptibility contrast MR imaging.
    AJR Am J Roentgenol. 2002 Mar;178(3):711-6 PMID: 11856703
  27. Contrast-enhanced MR imaging of malignant brain tumors.
    AJNR Am J Neuroradiol. 1985 Nov-Dec;6(6):855-62 PMID: 3934926
  28. MR imaging in an experimental model of brain tumor immunotherapy.
    AJNR Am J Neuroradiol. 1991 May-Jun;12(3):543-8 PMID: 2058511
  29. Basic fibroblast growth factor induces cell migration and proliferation after glia-specific gene transfer in mice.
    Proc Natl Acad Sci U S A. 1998 Feb 3;95(3):1218-23 PMID: 9448312
  30. Growth kinetics and treatment response of the intracerebral rat 9L brain tumor model: a quantitative in vivo study using magnetic resonance imaging.
    Clin Cancer Res. 1995 Jun;1(6):643-50 PMID: 9816027
  31. Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice.
    Nat Genet. 2000 May;25(1):55-7 PMID: 10802656
Article Info
Journal
Neoplasia (New York, N.Y.)
Abbr.
Neoplasia
ISSN
1522-8002
Published
2002-00-00
Pages
480-5
Language
English
Region
United States
NLM ID
100886622
PMCID
PMC1503661
Subset
IM
Grants
NCI NIH HHS · CA-08748 · United States
NCI NIH HHS · P30 CA008748 · United States
NCI NIH HHS · U01 CA894314-1 · United States
NCI NIH HHS · R24CA83084 · United States
NCI NIH HHS · R24 CA083084 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]